Lixte Biotechnology Holdings, Inc. · NASDAQ:LIXT
Holloway Michael Andrew received 25,000 Lixte Biotechnology Holdings, Inc. shares as an award (Form 4)
Traded Apr 15, 2026 · Filed Apr 17, 2026
On Apr 15, 2026, Holloway Michael Andrew (Director) received 25,000 Lixte Biotechnology Holdings, Inc. shares as an award, leaving 25,000 shares. Filed Apr 17, 2026 (Form 4).
- Awarded
- 25,000 shares
- Holding after
- 25,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Common Stock | Award | 25,000 | 25,000 | Direct |
Source
Related
- Lixte Biotechnology Holdings, Inc.
- Holloway Michael Andrew
- Lixte Biotechnology Holdings, Inc. shareholders
- Form 4 · Holloway Michael Andrew · Jul 2, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stazzone Peter · Jul 2, 2026
- Form 4 · Sawyer Jason David · Jul 2, 2026
- Form 4 · Pursglove Geordan Garrett · Jul 2, 2026
- Form 4 · Primus Guy Warren · Jul 2, 2026